Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
4,803 total articles
ECARX’s acquisition of DreamSmart pushes the company deeper into in-car software and content monetization. The move can accelerate recurring revenue and OEM relationships, but it is capital-intensive and raises execution risk. We lay out a mid-term swing trade that buys the thesis while limiting downside exposure.
Oscar Health (OSCR) is a high-growth ACA marketplace insurer that has suffered a sharp share-price reset. With membership growth, 2026 guidance for $18.7-19.0B revenue and $250-450M in operating earnings, and bargain-like multiples (EV/Sales ~0.18, P/S ~0.38), the risk/reward favors a constructive long position. This trade targets a full re‑rating …
Volaris (VLRS) has the network and cost discipline of an ultra-low-cost carrier, but a renewed oil shock and recent revenue softness create a window to short the stock over the mid-term. Enter at $7.65, stop at $8.40, target $6.00 on a 45-trading-day horizon.
Helios (HLIO) has moved from distressed lows to a constructive technical and fundamental setup. With solid free cash flow, manageable leverage and improving technical momentum, the stock looks actionable on a disciplined entry. This trade idea lays out an exact entry, stop and target tied to support, moving averages and valuation context — but it a…
Broadcom just crossed an inflection point: a strategic Triad AI partnership (deal details limited publicly) materially strengthens its custom-ASIC and data-center networking moats. Valuation is rich but supported by large free cash flow, strong returns on equity, and improving technicals. This trade plan targets capitalizing on continued enterprise…
I increased my Tesla position at $342.34 because the setup combines an oversold technical base, meaningful free cash flow, low leverage and a near-term product roadmap that could reaccelerate volumes. Valuation is full, so this is a tactical, growth-with-drawdown trade sized for conviction but capped for risk.
Coca-Cola HBC (CCHGY) looks buyable around $58.45. The company mixes predictable beverage volume recovery across Europe with margin resilience and a dividend yield near 1.9%. With a market cap of roughly $21.3B, a P/E around 20 and constructive technicals, this is a medium-risk, long-term trade aimed at recapturing the 52-week high while collecting…
Microsoft looks like a candidate where the selloff is driven by macro uncertainty rather than company-specific deterioration. For traders willing to accept medium risk, a controlled long with a clear stop and a mid-term horizon capitalizes on likely mean reversion as fundamentals and AI-driven revenue durability reassert themselves.
Teradyne has quietly moved from a cyclical semiconductor-test play to a diversified supplier of AI infrastructure and automation. Strong AI-related demand, expanding robotics revenue, healthy cash flow and low leverage support a long-biased trade. Valuation is rich vs. history but justified by rapid revenue/margin expansion; trade with a clear stop…
TSMC is the dominant foundry behind the AI compute boom. With a $1.88 trillion market cap, strong technical momentum, and hyperscaler capex forecasts supporting demand, a disciplined long trade into weakness makes sense. Entry at $364, stop $345, target $420 over a 180-trading-day horizon balances upside from continued AI investment against valuati…
Cardinal Energy looks positioned to compound cash flow in 2026 even if oil drifts around $75/bbl. The company’s production profile, capital discipline and hedging cadence create a favorable risk-reward: a defined-entry trade can capture upside from higher cash returns, deleveraging and potential multiple expansion while keeping downside contained w…
General Motors is generating meaningful free cash flow and trading at attractive multiples versus its cash-generation profile. I raise my tactical target on GM and recommend a mid-term long entry near $76 with a $92 target and a $69 stop. The trade banks on steady FCF, resilient truck demand and EV momentum, while respecting execution and macro ris…
Denison Mines (DNN) is a development-stage uranium company centered on the Wheeler River and Athabasca Basin joint ventures. With a market cap near $3.14B, active 2026 drilling (Wheeler North and Russell Lake JV programs), constructive technical setup and a manageable capital structure, Denison offers an asymmetric trade: near-term exploration cata…
Alibaba is building agentic AI capabilities (Qwen / Accio Work / Wukong) that can operate as digital employees for enterprises. The market has focused on macro and regulatory noise and is underpricing the revenue and enterprise-engagement optionality from agentic deployments. Technicals and sentiment suggest a tactical long with defined risk-reward…
Rolls‑Royce (RYCEY) is showing improving commercial aerospace aftermarket activity, steady defense demand and growing relevance in small modular reactors (SMRs). Technicals and liquidity patterns favor a bounce toward the 52‑week high. I’m upgrading to a buy for a mid‑term trade: entry $17.10, stop $15.50, target $19.50 over ~45 trading days, with …
I upgrade Amazon to a buy and propose a mid-term long trade. AWS's AI tailwind, improving momentum indicators and a valuation that still looks reasonable at ~30x earnings justify a tactical entry at $225.47. Target $255 with a $210 stop; keep position size disciplined given recent FCF weakness and macro risks.
DISCO (DSCSY) reported Q4 above management guidance and the stock sits well below its 52-week high despite a market cap of about $44.2B and a forward-looking memory-market tailwind. This trade idea lays out a mid-term (45 trading days) buy with precise entry, stop and target, a rationale tied to semicap demand and technical setup, and a balanced li…
Powell Industries has gone from deep cyclicality to a leadership position in custom electrical systems, driven by a $1.6 billion backlog, expanding automation capabilities, and steady dividend hikes. The stock is at its 52-week high and shows bullish momentum, but valuation is rich versus history. This is a swing trade: initiate a cautious long wit…
Eli Lilly's market leadership in GLP-1 obesity therapies and an expanding immunology pipeline justify a tactical long. The shares trade at a premium (market cap ~$895B, P/E ~41.5) but generate strong free cash flow and superior ROE. I'll go long LLY at $940 with a $1,100 target and $880 stop, structured for a long-term (180 trading days) hold while…
Diebold Nixdorf (DBD) looks set to benefit from renewed investor attention tied to expected index inclusion and a steady operational recovery. With positive free cash flow, improving retail product sales, and an EV/EBITDA of 9, the risk/reward favors a tactical long over the next several months. Entry: $80.00, Target: $95.00, Stop: $72.00.
Nvidia remains the dominant GPU and AI-platform supplier. Recent strategic moves — including a $2 billion partnership to cement optical interconnect and custom silicon access — plus massive free cash flow and ultra-high profitability make 2026 a plausible inflection year. The stock is expensive on multiples but backed by cash generation, low levera…
Micron is at the center of a structural memory shortage for AI workloads. Strong cash flow, high ROE, and a still-reasonable multiple create an asymmetric risk/reward. This trade idea outlines a tactical long with clear entry, stop and target and explains the catalysts and risks that will determine the outcome.
Magnolia Oil & Gas (MGY) trades at roughly $5.57B market cap with trailing free cash flow of $398.8M. Under a conservative 2026 strip scenario we model >$700M in FCF, which would cut P/FCF to the high-single digits and leave room for dividend hikes, buybacks or multiple expansion. Trade idea: initiate a long with a measured stop and a $35 target ov…
STAAR Surgical's preliminary Q1 2026 net sales of over $90 million - more than double the year-ago period - and an expanded FDA age label materially improve the bull case after shareholders rejected Alcon's takeover. The share price gap higher looks justified, but negative free cash flow and regional headwinds keep risk elevated. This is a tactical…
NovaBridge Biosciences ($NBP) trades at a $281M market cap with a heavy clinical focus in oncology and ophthalmology. Positive data on immuno-oncology assets have already moved sentiment; a favorable Givastomig readout or advancement could re-rate the stock meaningfully from its current $2.44 handle. This is a tactical swing trade: entry at $2.44, …
